Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
Expands manufacturing push & locks in major growth deals
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
Its a major breakthrough for women’s ovarian cancer care in Europe
New targeted pill offers hope for adults and teens with moderate-to-severe plaque psoriasis
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
